Bristol-Myers Squibb
NYSE BMY · Princeton, NJ
Works in Cardiovascular · Dermatology · Genetic & rare · GI & liver · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Ophthalmology · Psychiatry · Renal & urogenital · Respiratory · Women's health
Bristol-Myers Squibb is a clinical trial sponsor based in Princeton, NJ, listed as NYSE BMY. It has 188 active clinical trials with 101,065 planned participants, across 16 therapeutic areas. Since 2021 it has completed 449 trials and stopped 77 early. Its FDA record on file shows 1 inspection.
Trial track record · since 2021
FDA record
Recent FDA actions
Financials · NYSE BMY
Fundraising
Pipeline · 188 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
19 approved drug applications with a product on the market.
Questions about Bristol-Myers Squibb
No warning letter naming Bristol-Myers Squibb is on file. FDA has published 1 inspection classification naming it.
FDA has posted 1 inspection classification naming Bristol-Myers Squibb. The latest inspection ended on 2026-04-28 and was classified NAI (no action indicated). FDA posts a classification after its review, often months after the inspection ended.
Bristol-Myers Squibb is lead sponsor of 188 active clinical trials on ClinicalTrials.gov, with 101,065 planned participants, in Cardiovascular, Dermatology, Genetic & rare, GI & liver and other areas. Since 2021 it has completed 449 trials and stopped 77 early.
Bristol-Myers Squibb is based in Princeton, NJ and is listed as NYSE BMY. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Bristol-Myers Squibb; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-16.
The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.
Approve Suite is not affiliated with Bristol-Myers Squibb.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.